Cheson, B. D., Byrd, J. C., Rai, K. R., Kay, N. E., O'Brien, S. M., Flinn, I. W., . . . Kipps, T. J. (2012). Novel Targeted Agents and the Need to Refine Clinical End Points in Chronic Lymphocytic Leukemia. American Society of Clinical Oncology.
Styl cytowania ChicagoCheson, Bruce D., John C. Byrd, Kanti R. Rai, Neil E. Kay, Susan M. O'Brien, Ian W. Flinn, Adrian Wiestner, i Thomas J. Kipps. Novel Targeted Agents and the Need to Refine Clinical End Points in Chronic Lymphocytic Leukemia. American Society of Clinical Oncology, 2012.
Styl cytowania MLACheson, Bruce D., et al. Novel Targeted Agents and the Need to Refine Clinical End Points in Chronic Lymphocytic Leukemia. American Society of Clinical Oncology, 2012.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..